Literature DB >> 11599298

Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis.

R C Brown1, V Papadopoulos.   

Abstract

The peripheral-type benzodiazepine receptor (PBR) has been demonstrated to be critical for steroidogenesis in all steroid-producing tissues. Here, we review the identification and characterization of the PBR, the evidence pointing to its function as a cholesterol pore involved in transporting cholesterol from the cytoplasm of steroid-producing cells into the inner mitochondrial membrane where it is metabolized, and the known mechanisms regulating its function. We present data on the functions of the PBR in the adrenal gland, a classical steroidogenic tissue, and in the brain, which has only recently been proven to be steroidogenic. Finally, we discuss other potential roles for the PBR in pathological conditions, including cancer, neurodegeneration, and neurotoxicity, and a broader role for the PBR in mediating intracellular cholesterol transport/compartmentalization, which may or may not be linked to steroid biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599298     DOI: 10.1016/s0074-7742(01)46061-2

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  14 in total

1.  Progesterone treatment normalizes the levels of cell proliferation and cell death in the dentate gyrus of the hippocampus after traumatic brain injury.

Authors:  Cindy K Barha; Tauheed Ishrat; Jonathan R Epp; Liisa A M Galea; Donald G Stein
Journal:  Exp Neurol       Date:  2011-06-13       Impact factor: 5.330

2.  Neurosteroid modulation of respiratory rhythm in rats during the perinatal period.

Authors:  Jun Ren; John J Greer
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

3.  Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis.

Authors:  Joseph L Mankowski; Suzanne E Queen; Patrick J Tarwater; Robert J Adams; Tomas R Guilarte
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 4.  On the role of skin in the regulation of local and systemic steroidogenic activities.

Authors:  Andrzej T Slominski; Pulak R Manna; Robert C Tuckey
Journal:  Steroids       Date:  2015-05-16       Impact factor: 2.668

5.  Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis.

Authors:  F Mattner; A Katsifis; M Staykova; P Ballantyne; D O Willenborg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-11-20       Impact factor: 9.236

6.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Authors:  M Cosenza-Nashat; M-L Zhao; H-S Suh; J Morgan; R Natividad; S Morgello; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12-11       Impact factor: 8.090

7.  Increasing 3alpha,5alpha-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social, and sexual behavior of naturally receptive rats.

Authors:  Cheryl A Frye; Jason J Paris; Madeline E Rhodes
Journal:  Reproduction       Date:  2008-09-25       Impact factor: 3.906

8.  In the ventral tegmental area picrotoxin blocks FGIN 1-27-induced increases in sexual behavior of rats and hamsters.

Authors:  Sandra M Petralia; Cheryl A Frye
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

Review 9.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair.

Authors:  Ming-Kai Chen; Tomás R Guilarte
Journal:  Pharmacol Ther       Date:  2008-02-09       Impact factor: 12.310

10.  Brain microglia express steroid-converting enzymes in the mouse.

Authors:  Andres Gottfried-Blackmore; Amanda Sierra; Peter H Jellinck; Bruce S McEwen; Karen Bulloch
Journal:  J Steroid Biochem Mol Biol       Date:  2008-02-02       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.